1.33. Analysis.

Comparison 1 BDP v BUD crossover design studies, no OCS: all doses, Outcome 33 Plasma cortisol 30 min post 250 mcg tetracosactrin (nmol/L).

Comparison 1 BDP v BUD crossover design studies, no OCS: all doses, Outcome 33 Plasma cortisol 30 min post 250 mcg tetracosactrin (nmol/L).